Optiscan Imaging (ASX:OIL) has been granted a trading halt by the ASX pending changes to the board of directors.
Optiscan’s second generation animal imaging system, CellLIVE, is expected to generate its first sales in the September quarter.
The halt will remain in place until the opening of trade on Wednesday 22nd July 2015, or earlier if an announcement is made to the market.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.